175 related articles for article (PubMed ID: 23411465)
1. A novel therapeutic molecule against HTLV-1 infection targeting provirus.
Tanaka A; Takeda S; Kariya R; Matsuda K; Urano E; Okada S; Komano J
Leukemia; 2013 Aug; 27(8):1621-7. PubMed ID: 23411465
[TBL] [Abstract][Full Text] [Related]
2. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms.
Taniguchi Y; Nosaka K; Yasunaga J; Maeda M; Mueller N; Okayama A; Matsuoka M
Retrovirology; 2005 Oct; 2():64. PubMed ID: 16242045
[TBL] [Abstract][Full Text] [Related]
3. Human T-cell leukemia virus type 1 (HTLV-1) infection of mice: proliferation of cell clones with integrated HTLV-1 provirus in lymphoid organs.
Tanaka M; Sun B; Fang J; Nitta T; Yoshida T; Kohtoh S; Kikukawa H; Hanai S; Uchida K; Miwa M
J Virol; 2001 May; 75(9):4420-3. PubMed ID: 11287593
[TBL] [Abstract][Full Text] [Related]
4. The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma.
Cook LB; Melamed A; Niederer H; Valganon M; Laydon D; Foroni L; Taylor GP; Matsuoka M; Bangham CR
Blood; 2014 Jun; 123(25):3925-31. PubMed ID: 24735963
[TBL] [Abstract][Full Text] [Related]
5. 5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo.
Koiwa T; Hamano-Usami A; Ishida T; Okayama A; Yamaguchi K; Kamihira S; Watanabe T
J Virol; 2002 Sep; 76(18):9389-97. PubMed ID: 12186921
[TBL] [Abstract][Full Text] [Related]
6. Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis.
Miyazaki M; Yasunaga J; Taniguchi Y; Tamiya S; Nakahata T; Matsuoka M
J Virol; 2007 Jun; 81(11):5714-23. PubMed ID: 17344291
[TBL] [Abstract][Full Text] [Related]
7. Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis.
Ishikawa C; Nakachi S; Senba M; Sugai M; Mori N
Carcinogenesis; 2011 Jan; 32(1):110-9. PubMed ID: 20974684
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo.
Fan J; Ma G; Nosaka K; Tanabe J; Satou Y; Koito A; Wain-Hobson S; Vartanian JP; Matsuoka M
J Virol; 2010 Jul; 84(14):7278-87. PubMed ID: 20463074
[TBL] [Abstract][Full Text] [Related]
9. Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100.
Watanabe T; Yamashita S; Ureshino H; Kamachi K; Kurahashi Y; Fukuda-Kurahashi Y; Yoshida N; Hattori N; Nakamura H; Sato A; Kawaguchi A; Sueoka-Aragane N; Kojima K; Okada S; Ushijima T; Kimura S; Sueoka E
Blood; 2020 Aug; 136(7):871-884. PubMed ID: 32391874
[TBL] [Abstract][Full Text] [Related]
10. Integration of proviral DNA into the PDGF beta-receptor gene in HTLV-I-infected T-cells results in a novel tyrosine kinase product with transforming activity.
Chi KD; McPhee RA; Wagner AS; Dietz JJ; Pantazis P; Goustin AS
Oncogene; 1997 Aug; 15(9):1051-7. PubMed ID: 9285559
[TBL] [Abstract][Full Text] [Related]
11. Proviral status of HTLV-1 integrated into the host genomic DNA of adult T-cell leukemia cells.
Kamihira S; Sugahara K; Tsuruda K; Minami S; Uemura A; Akamatsu N; Nagai H; Murata K; Hasegawa H; Hirakata Y; Takasaki Y; Tsukasaki K; Yamada Y
Clin Lab Haematol; 2005 Aug; 27(4):235-41. PubMed ID: 16048490
[TBL] [Abstract][Full Text] [Related]
12. Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites.
Mori N; Ueda A; Ikeda S; Yamasaki Y; Yamada Y; Tomonaga M; Morikawa S; Geleziunas R; Yoshimura T; Yamamoto N
Cancer Res; 2000 Sep; 60(17):4939-45. PubMed ID: 10987310
[TBL] [Abstract][Full Text] [Related]
13. Activation of HTLV-I long terminal repeat by apoptosis inducing agents: mechanism and implications for HTLV-I pathogenicity (review).
Schavinsky-Khrapunsky Y; Gold E; Ben-Aroya Z; Torgeman A; Aboud M; Huleihel M
Int J Mol Med; 2003 Jan; 11(1):3-11. PubMed ID: 12469209
[TBL] [Abstract][Full Text] [Related]
14. High levels of AP-2-binding activity in cell lines infected with human T-cell leukemia virus type I: possible enhancement of AP-2 binding by human T-cell leukemia virus type I tax.
Mori N; Prager D
Cancer Res; 1996 Feb; 56(4):779-82. PubMed ID: 8631013
[TBL] [Abstract][Full Text] [Related]
15. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia.
Tamiya S; Matsuoka M; Etoh K; Watanabe T; Kamihira S; Yamaguchi K; Takatsuki K
Blood; 1996 Oct; 88(8):3065-73. PubMed ID: 8874205
[TBL] [Abstract][Full Text] [Related]
16. Role of microRNAs in HTLV-1 infection and transformation.
Ruggero K; Corradin A; Zanovello P; Amadori A; Bronte V; Ciminale V; D'Agostino DM
Mol Aspects Med; 2010 Oct; 31(5):367-82. PubMed ID: 20600265
[TBL] [Abstract][Full Text] [Related]
17. Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease.
Araya N; Takahashi K; Sato T; Nakamura T; Sawa C; Hasegawa D; Ando H; Aratani S; Yagishita N; Fujii R; Oka H; Nishioka K; Nakajima T; Mori N; Yamano Y
Antivir Ther; 2011; 16(1):89-98. PubMed ID: 21311112
[TBL] [Abstract][Full Text] [Related]
18. The diversity of the structure and genomic integration sites of HTLV-1 provirus in MT-2 cell lines.
Hashikura Y; Umeki K; Umekita K; Nomura H; Yamamoto I; Hasegawa H; Yanagihara K; Okayama A
Hum Cell; 2016 Jul; 29(3):122-9. PubMed ID: 26940204
[TBL] [Abstract][Full Text] [Related]
19. Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo.
Hiyoshi M; Okuma K; Tateyama S; Takizawa K; Saito M; Kuramitsu M; Araki K; Morishita K; Okada S; Yamamoto N; Biragyn A; Yamaguchi K; Hamaguchi I
Retrovirology; 2015 Aug; 12():73. PubMed ID: 26289727
[TBL] [Abstract][Full Text] [Related]
20. The microRNA regulatory network in normal- and HTLV-1-transformed T cells.
D'Agostino DM; Zanovello P; Watanabe T; Ciminale V
Adv Cancer Res; 2012; 113():45-83. PubMed ID: 22429852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
